CPS TECHNOLOGIES CORP (CPSH)

US12619F1049 - Common Stock

1.46  0 (0%)

Fundamental Rating

3

CPSH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for CPSH as it has an excellent financial health rating, but there are worries on the profitability. CPSH has a expensive valuation and it also scores bad on growth.



3

1. Profitability

1.1 Basic Checks

CPSH had negative earnings in the past year.
In the past year CPSH has reported a negative cash flow from operations.
CPSH had positive earnings in 4 of the past 5 years.
Of the past 5 years CPSH 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -10.41%, CPSH is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
The Return On Equity of CPSH (-12.95%) is worse than 62.60% of its industry peers.
Industry RankSector Rank
ROA -10.41%
ROE -12.95%
ROIC N/A
ROA(3y)11.1%
ROA(5y)7.43%
ROE(3y)15.31%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CPSH's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of CPSH has grown nicely.
The Gross Margin of CPSH (5.93%) is worse than 86.99% of its industry peers.
In the last couple of years the Gross Margin of CPSH has grown nicely.
CPSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.93%
OM growth 3Y12.26%
OM growth 5YN/A
PM growth 3Y4.49%
PM growth 5YN/A
GM growth 3Y7.43%
GM growth 5Y12.94%

7

2. Health

2.1 Basic Checks

CPSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CPSH has been increased compared to 1 year ago.
CPSH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CPSH has been reduced compared to a year ago.

2.2 Solvency

CPSH has an Altman-Z score of 2.89. This is not the best score and indicates that CPSH is in the grey zone with still only limited risk for bankruptcy at the moment.
CPSH's Altman-Z score of 2.89 is in line compared to the rest of the industry. CPSH outperforms 47.97% of its industry peers.
CPSH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.89
ROIC/WACCN/A
WACC10.05%

2.3 Liquidity

CPSH has a Current Ratio of 3.99. This indicates that CPSH is financially healthy and has no problem in meeting its short term obligations.
CPSH has a better Current ratio (3.99) than 70.73% of its industry peers.
A Quick Ratio of 2.78 indicates that CPSH has no problem at all paying its short term obligations.
CPSH has a Quick ratio of 2.78. This is in the better half of the industry: CPSH outperforms 68.29% of its industry peers.
Industry RankSector Rank
Current Ratio 3.99
Quick Ratio 2.78

1

3. Growth

3.1 Past

CPSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -237.84%.
Measured over the past years, CPSH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.20% on average per year.
Looking at the last year, CPSH shows a very negative growth in Revenue. The Revenue has decreased by -18.54% in the last year.
CPSH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.01% yearly.
EPS 1Y (TTM)-237.84%
EPS 3Y10.2%
EPS 5YN/A
EPS Q2Q%-817.9%
Revenue 1Y (TTM)-18.54%
Revenue growth 3Y9.7%
Revenue growth 5Y5.01%
Sales Q2Q%-32.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CPSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CPSH!.
Industry RankSector Rank
Dividend Yield N/A

CPS TECHNOLOGIES CORP

NASDAQ:CPSH (11/22/2024, 9:55:38 AM)

1.46

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap21.21M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.41%
ROE -12.95%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 5.93%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.99
Quick Ratio 2.78
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-237.84%
EPS 3Y10.2%
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-18.54%
Revenue growth 3Y9.7%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y